E. Lourida

781 total citations
14 papers, 566 citations indexed

About

E. Lourida is a scholar working on Epidemiology, Biochemistry and Immunology. According to data from OpenAlex, E. Lourida has authored 14 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 5 papers in Biochemistry and 5 papers in Immunology. Recurrent topics in E. Lourida's work include Antioxidant Activity and Oxidative Stress (5 papers), Atherosclerosis and Cardiovascular Diseases (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). E. Lourida is often cited by papers focused on Antioxidant Activity and Oxidative Stress (5 papers), Atherosclerosis and Cardiovascular Diseases (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). E. Lourida collaborates with scholars based in Greece, United States and Cyprus. E. Lourida's co-authors include Alexandros D. Tselepis, Moses Elisaf, Eleni C. Papavasiliou, A. Georgiadis, Alexandros A. Drosos, Christina Kostara, Yannis Alamanos, Vasilis Tsimihodimos, Theodosios D. Filippatos and Irene F. Gazi and has published in prestigious journals such as Journal of Lipid Research, Clinical Chemistry and Atherosclerosis.

In The Last Decade

E. Lourida

14 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Lourida Greece 11 231 187 152 90 84 14 566
Anne Cogny France 10 201 0.9× 53 0.3× 157 1.0× 51 0.6× 53 0.6× 12 425
Yuen Yin Lee United States 9 153 0.7× 316 1.7× 103 0.7× 75 0.8× 108 1.3× 9 612
Veronika Binder Norway 9 158 0.7× 38 0.2× 178 1.2× 57 0.6× 81 1.0× 12 527
Sonia-Athena P. Karabina Greece 10 382 1.7× 44 0.2× 237 1.6× 136 1.5× 107 1.3× 13 750
Claudia Huesca‐Gómez Mexico 12 96 0.4× 60 0.3× 90 0.6× 42 0.5× 57 0.7× 38 415
M.A. Sardo Italy 19 131 0.6× 39 0.2× 79 0.5× 188 2.1× 96 1.1× 37 762
Maria Donata Di Taranto Italy 18 420 1.8× 40 0.2× 103 0.7× 51 0.6× 160 1.9× 48 751
Michelle R. Joshi United States 8 315 1.4× 25 0.1× 210 1.4× 113 1.3× 101 1.2× 8 598
C B Marenah United Kingdom 17 289 1.3× 20 0.1× 167 1.1× 49 0.5× 37 0.4× 30 670
Mitsuaki TAKEDA Japan 8 368 1.6× 30 0.2× 234 1.5× 58 0.6× 36 0.4× 11 562

Countries citing papers authored by E. Lourida

Since Specialization
Citations

This map shows the geographic impact of E. Lourida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Lourida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Lourida more than expected).

Fields of papers citing papers by E. Lourida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Lourida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Lourida. The network helps show where E. Lourida may publish in the future.

Co-authorship network of co-authors of E. Lourida

This figure shows the co-authorship network connecting the top 25 collaborators of E. Lourida. A scholar is included among the top collaborators of E. Lourida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Lourida. E. Lourida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Lourida, E., A. Georgiadis, Eleni C. Papavasiliou, et al.. (2007). Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A2. Arthritis Research & Therapy. 9(1). R19–R19. 32 indexed citations
2.
Παπαθανασίου, Αθανάσιος, E. Lourida, Loukas D. Tsironis, John Goudevenos, & Alexandros D. Tselepis. (2006). Short- and long-term elevation of autoantibody titers against oxidized LDL in patients with acute coronary syndromes. Atherosclerosis. 196(1). 289–297. 18 indexed citations
3.
Tsouli, Sofia, Dimitrios N. Kiortsis, E. Lourida, et al.. (2006). Autoantibody titers against OxLDL are correlated with Achilles tendon thickness in patients with familial hypercholesterolemia. Journal of Lipid Research. 47(10). 2208–2214. 37 indexed citations
4.
Georgiadis, A., Eleni C. Papavasiliou, E. Lourida, et al.. (2006). Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment – a prospective, controlled study. Arthritis Research & Therapy. 8(3). R82–R82. 190 indexed citations
5.
Tentolouris, Nikolaοs, Andreas Stylianou, E. Lourida, et al.. (2006). High postprandial triglyceridemia in patients with type 2 diabetes and microalbuminuria. Journal of Lipid Research. 48(1). 218–225. 28 indexed citations
6.
Lourida, E., Αθανάσιος Παπαθανασίου, John Goudevenos, & Alexandros D. Tselepis. (2006). The low-density lipoprotein (LDL)-associated PAF-acetylhydrolase activity and the extent of LDL oxidation are important determinants of the autoantibody titers against oxidized LDL in patients with coronary artery disease. Prostaglandins Leukotrienes and Essential Fatty Acids. 75(2). 117–126. 12 indexed citations
7.
Tentolouris, Nikolaοs, Eleni Boutati, Alexandros D. Tselepis, et al.. (2005). Acute nateglinide administration in subjects with type 2 diabetes: effects on postprandial metabolism, coagulation, and fibrinolysis. Nutrition Metabolism and Cardiovascular Diseases. 15(1). 6–12. 11 indexed citations
8.
Gazi, Irene F., E. Lourida, Theodosios D. Filippatos, et al.. (2005). Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Small, Dense LDL Particles in Human Plasma. Clinical Chemistry. 51(12). 2264–2273. 144 indexed citations
9.
Tsouli, Sofia, Dimitrios N. Kiortsis, E. Lourida, et al.. (2005). W12-P-078 Lack of association between carotid intima media thickness and PAF-acetylhydrolase mass and activity in patients with primary hyperlipidemia. Atherosclerosis Supplements. 6(1). 81–81. 1 indexed citations
10.
Tselepis, Alexandros D., et al.. (2005). Comparative Antioxidant Effectiveness of White and Red Wine and Their Phenolic Extracts Towards Low-Density Lipoprotein Oxidation. Food Biotechnology. 19(1). 1–14. 9 indexed citations
11.
Kiortsis, Dimitrios N., Sofia Tsouli, E. Lourida, et al.. (2005). Lack of Association Between Carotid Intima-Media Thickness and PAF-Acetylhydrolase Mass and Activity in Patients with Primary Hyperlipidemia. Angiology. 56(4). 451–458. 26 indexed citations
12.
Tsironis, Loukas D., Christos S. Katsouras, E. Lourida, et al.. (2004). Reduced PAF-acetylhydrolase activity associated with Lp(a) in patients with coronary artery disease. Atherosclerosis. 177(1). 193–201. 35 indexed citations
13.
Lourida, E., Sofia Tsouli, Dimitrios N. Kiortsis, Moses Elisaf, & A. Tselepis. (2004). M.574 The levels of autoantibodies against oxidized LDL in hypercholesterolemic patients are influenced by the LDL-associated PAF-acetylhydrolase activity. Atherosclerosis Supplements. 5(1). 133–133. 1 indexed citations
14.
Kakafika, Anna I., Vasilis Tsimihodimos, Afroditi P. Tambaki, et al.. (2003). The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity. Journal of Lipid Research. 44(10). 1919–1926. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026